Precipio, Inc. (PRPO): Price and Financial Metrics
PRPO Price/Volume Stats
| Current price | $6.18 | 52-week high | $14.80 |
| Prev. close | $5.86 | 52-week low | $4.75 |
| Day low | $5.71 | Volume | 8,100 |
| Day high | $6.30 | Avg. volume | 6,283 |
| 50-day MA | $6.36 | Dividend yield | N/A |
| 200-day MA | $6.67 | Market Cap | 8.84M |
PRPO Stock Price Chart Interactive Chart >
Precipio, Inc. (PRPO) Company Bio
Precipio, Inc. operates as a biotechnology company. The Company offers medicines for oncology, cardiology, neurology, and inherited diseases. Precipio also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Precipio serves customers in the United States.
Latest PRPO News From Around the Web
Below are the latest news stories about PRECIPIO INC that investors may wish to consider to help them evaluate PRPO as an investment opportunity.
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024NEW HAVEN, Conn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) shares thoughts and reflections looking back at 2023, and forward to 2024. At the start of 2023, management set three goals, all focused on achieving cash flow breakeven going forward: Target #1: For the pathology division, reaching estimated annualized revenues of $14M, which was expected to enable the division to achieve cash flow breakeven based on its cost stru |
Precipio Announces Q3-2023 Shareholder Update CallConference Call to be held on November 20th, 2023 at 5:00 PM ESTNEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2023 corporate update call on November 20th, 2023 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. |
When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?Precipio, Inc. ( NASDAQ:PRPO ) is possibly approaching a major achievement in its business, so we would like to shine... |
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-202228% Revenue Increase Is Major Step Toward Company BreakevenNEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that Q3-2023 (unaudited) revenues have increased 28% to $4.5M from $3.5M in Q2-2023, and have more than doubled from $2.2M from Q3-2022. The combination of ongoing revenue growth in both the pathology and products divisions, alongside efficiency and cost reduction initiatives has rapidly moved the company towa |
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023Company anticipates current cash levels sufficient to reach breakevenNEW HAVEN, Conn., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that the combination of revenue growth and cost cutting initiatives has reduced Cash Burn From Operations (CBFO) by 59% compared to the same quarter last year, from approximately $2.5M/quarter to $1M/quarter. Management has set a target of reaching financial independence with its current cash reserve |
PRPO Price Returns
| 1-mo | 1.58% |
| 3-mo | -4.00% |
| 6-mo | -18.79% |
| 1-year | -46.82% |
| 3-year | -84.15% |
| 5-year | -93.56% |
| YTD | -4.92% |
| 2023 | -41.06% |
| 2022 | -65.10% |
| 2021 | -23.67% |
| 2020 | 0.98% |
| 2019 | -8.89% |
Continue Researching PRPO
Want to see what other sources are saying about Precipio Inc's financials and stock price? Try the links below:Precipio Inc (PRPO) Stock Price | Nasdaq
Precipio Inc (PRPO) Stock Quote, History and News - Yahoo Finance
Precipio Inc (PRPO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...